Table 1.
Characteristic | No. of patients | Median (range) or percent | |
---|---|---|---|
Age | 51 (29–86) | ||
Age group (%) | <50 | 83 | 43.9 |
≥50 | 106 | 56.1 | |
Race (%) | Caucasian | 91 | 48.1 |
African American | 92 | 48.7 | |
Other races | 6 | 3.2 | |
Stage (%) | 1 | 48 | 25.4 |
2 | 52 | 27.5 | |
3 | 26 | 13.8 | |
4 | 63 | 33.3 | |
ER (%) | Positive | 109 | 57.7 |
Negative | 69 | 36.5 | |
Unknown | 11 | 5.8 | |
PR (%) | Positive | 88 | 46.6 |
Negative | 89 | 47.1 | |
Unknown | 12 | 6.3 | |
HER2 (%) | Positive | 34 | 18.0 |
Negative | 119 | 63.0 | |
Unknown | 36 | 19.0 | |
Grade (%) | 1 | 30 | 15.9 |
2 | 43 | 22.7 | |
3 | 76 | 40.2 | |
Unknown | 40 | 21.2 | |
Tumor type (%) | Ductal | 152 | 80.4 |
Lobular | 18 | 9.5 | |
Other* | 19 | 10.1 | |
Lymph node status (Stage 1–3 patients) | Negative | 63 | 50.0 |
Positive | 45 | 35.7 | |
Unknown | 18 | 14.37 | |
Tumor size (cm) Stage 1–3 patients | <2 cm | 63 | 50.0 |
2–5 cm | 36 | 28.6 | |
>5 cm | 12 | 9.5 | |
Unknown | 15 | 11.9 |
Note:
Other includes: medullary, mucinous, tubular, colloid, and unknown.
Abbreviations: ER, estrogen receptor; PR, Progesterone Receptor; Her-2, human epidermal growth factor receptor-2.